Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies.
about
Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis.Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.Evidence from the anti-idiotypic network that the acetylcholine receptor is a rabies virus receptorVaccination with a live retrovirus: the nature of the protective immune responseNovel Approaches to the Prevention and Treatment of RabiesNovel vaccines to human rabiesDevelopment of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus.Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody.Protective effect of different anti-rabies virus VHH constructs against rabies disease in mice.Postexposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the Central Nervous System (CNS) through the rapid induction of genes relevant to adaptive immunity in CNS tissues.Rabies virus antinucleoprotein antibody protects against rabies virus challenge in vivo and inhibits rabies virus replication in vitroDirect entry of rabies virus into the central nervous system without prior local replicationDelineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system.Further studies on the mechanism of rabies virus neutralization by a viral glycoprotein-specific monoclonal antibody, #1-46-12.Preparation and diagnostic use of a novel recombinant single-chain antibody against rabies virus glycoprotein.
P2860
Q24520604-8EF1AD71-A2E9-400C-9F38-5779772D8535Q24531953-3DBE6CC0-9D5C-445B-B099-7EA1A779C8B0Q27486014-DF0BA511-C133-4056-9EDC-2C666A3FBE55Q28335614-254C392A-97B9-43D4-8E2F-60E6D5E6D670Q28818601-B06F4B43-7BB4-4528-AE8F-ADB2B57E0DC3Q33507253-37B157A3-6932-46FF-B24E-6B7E6D3E0782Q33514828-268C0DFE-3FE7-4815-9D1E-B038860E1798Q33782269-534D3CE0-77BC-482B-A62E-F2965EDBC9A3Q33816066-6DC294B6-5C35-4085-9BF9-BE1B2B8C84F3Q34408085-750620FB-1310-49B9-95D5-C0A66A1A4EBFQ35826226-3B07AAC9-92E5-4C29-ABD4-DD5FCCBCB254Q36653651-173B931A-153A-4900-9C25-6E1EBA57727DQ36689273-C218E77A-1433-4B78-A83F-D5E5DE6BC96BQ37141934-9CA983B7-E3FA-4BB9-AFC2-97ECEB83009DQ40382923-EC1239C7-2581-403F-B381-9ABBD9BD959CQ42240366-1928B5A4-7C9B-4692-B1E5-A986B729A98F
P2860
Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies.
@ast
Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies.
@en
type
label
Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies.
@ast
Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies.
@en
prefLabel
Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies.
@ast
Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies.
@en
P2093
P2860
P356
P1476
Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies.
@en
P2093
B Dietzschold
C E Rupprecht
C L Schumacher
H Koprowski
P2860
P304
P356
10.1172/JCI114260
P407
P577
1989-09-01T00:00:00Z